Vertigo, a common clinical symptom characterized by the perception of motion where none exists, can be a diagnostic challenge for healthcare professionals. Understanding the pathophysiology and clinical approach to vertigo is paramount to ensure effective patient management.
Vertigo is primarily a manifestation of vestibular dysfunction. It arises from an imbalance in the neuronal activity of the bilateral vestibular nuclei. This can be due to peripheral causes like benign paroxysmal positional vertigo (BPPV), Meniere's disease, or vestibular neuritis, or central causes such as cerebrovascular disease or migraines.
The clinical approach to vertigo begins with a detailed history and physical examination. The temporal pattern of vertigo, associated symptoms like tinnitus or hearing loss, and provoking factors should be thoroughly evaluated. Physical examination should include Dix-Hallpike and head impulse tests.
Basic investigations include complete blood counts, electrolytes, and imaging studies. More specific tests like electronystagmography (ENG), videonystagmography (VNG), or magnetic resonance imaging (MRI) may be necessary based on the clinical suspicion. Audiometric studies can be useful in cases of suspected Meniere's disease.
Management of vertigo depends on the underlying cause. BPPV can be managed with canalith repositioning maneuvers while vestibular suppressants are used for vestibular neuritis. For Meniere's disease, a combination of dietary modification and diuretics is often effective. In refractory cases, vestibular rehabilitation therapy or surgery may be considered.
Vertigo is a complex symptom that requires a comprehensive clinical approach for accurate diagnosis and effective management. A clear understanding of its pathophysiology, clinical presentation, diagnostic investigations, and management strategies will enhance the ability of healthcare professionals to provide optimal patient care.
1.
Injecting PD-1 Drug Directly Into Oral Precancers Shrinks Lesions
2.
Sevabertinib Approved for First-Line Mutated NSCLC
3.
After three years, responses to mounetuzumab in follicular lymphoma are still stable.
4.
FDA Bans Red Dye No. 3 From Foods, Ingested Drugs
5.
AI can identify women at risk of breast cancer years in advance: Study
1.
Revolutionizing Cancer Treatment: Advances in Immunotherapy and Cell Therapy
2.
Pediatric Tumor Microenvironment Evolution: Mechanisms, Clinical Impact, and Therapeutic Implications
3.
Hematopoietic Stem Cell Activity Biomarkers in Aging
4.
Bone-Marrow Immune Cell Competition: Mechanisms, Clinical Implications, and Emerging Therapeutic Perspectives
5.
The Truth About TAR Syndrome: Understanding the Rare Genetic Disorder
1.
International Conference on Innovations in Critical Care for Oncology and Cardiology
2.
International Conference on Oncology, Cardiology and Critical Care Policy
3.
International Conference on Oncology, Cancer Prevention and Public Health
4.
International Conference on Cancer Nursing and Rehabilitation Strategies
5.
International Conference on Best Practices in Oncology, Cardiology and Critical Care
1.
Untangling The Best Treatment Approaches For ALK Positive Lung Cancer - Part VIII
2.
A New Era in Managing Cancer-Associated Thrombosis
3.
Emerging Concepts in Hematology
4.
The Reign of the CROWN Trial and the Dawn of a New Era in Frontline Management- Further Discussion
5.
An Eagles View - Evidence-based Discussion on Iron Deficiency Anemia- Panel Discussion III
© Copyright 2026 Hidoc Dr. Inc.
Terms & Conditions - LLP | Inc. | Privacy Policy - LLP | Inc. | Account Deactivation